日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2013/03/07 | 06 : 57 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/15 | 05 : 57 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/08 | 06 : 29 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/06 | 07 : 12 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/06 | 07 : 10 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/06 | 07 : 10 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/06 | 06 : 30 | GlobeNewswire Inc. | Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/05 | 06 : 41 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/05 | 06 : 32 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/02 | 07 : 06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/02/02 | 07 : 04 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/29 | 02 : 21 | Zacks | PTX Reduces Sales Force, CFO Quits - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/19 | 06 : 23 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/05 | 03 : 15 | Zacks | Pernix Acquires Cypress and Hawthorn - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 09 : 02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 09 : 01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
2013/01/04 | 08 : 46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |